ROYAL BANK OF CANADA - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 30 filers reported holding BIOLINERX LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BIOLINERX LTD
ValueSharesWeighting
Q2 2019$1,0000.0%3,0000.0%0.00%
Q1 2019$1,0000.0%3,0000.0%0.00%
Q4 2018$1,000
-66.7%
3,0000.0%0.00%
Q3 2018$3,0000.0%3,0000.0%0.00%
Q2 2018$3,0000.0%3,0000.0%0.00%
Q1 2018$3,000
+200.0%
3,000
+200.0%
0.00%
Q4 2017$1,000
-66.7%
1,000
-66.7%
0.00%
Q3 2017$3,0000.0%3,0000.0%0.00%
Q2 2017$3,0000.0%3,0000.0%0.00%
Q1 2017$3,000
-25.0%
3,000
-25.0%
0.00%
Q4 2016$4,0000.0%4,0000.0%0.00%
Q3 2016$4,0000.0%4,0000.0%0.00%
Q2 2016$4,0000.0%4,0000.0%0.00%
Q1 2016$4,0000.0%4,000
+33.3%
0.00%
Q4 2015$4,000
-20.0%
3,0000.0%0.00%
Q3 2015$5,000
-37.5%
3,0000.0%0.00%
Q2 2015$8,000
+100.0%
3,000
+50.0%
0.00%
Q1 2015$4,000
+33.3%
2,0000.0%0.00%
Q4 2014$3,0000.0%2,0000.0%0.00%
Q3 2014$3,000
-88.0%
2,000
-83.3%
0.00%
Q2 2014$25,000
-7.4%
12,0000.0%0.00%
Q1 2014$27,000
-20.6%
12,0000.0%0.00%
Q4 2013$34,000
+25.9%
12,0000.0%0.00%
Q3 2013$27,000
+42.1%
12,0000.0%0.00%
Q2 2013$19,00012,0000.00%
Other shareholders
BIOLINERX LTD shareholders Q3 2017
NameSharesValueWeighting ↓
Senvest Management, LLC 3,603,300$4,684,0000.35%
Broadfin Capital, LLC 3,500,000$4,550,0000.28%
Opaleye Management Inc. 250,000$325,0000.14%
Benchmark Capital Advisors 47,000$61,0000.05%
NEXT Financial Group, Inc 37,500$48,0000.02%
MENTA CAPITAL LLC 88,517$115,0000.02%
Orbimed Advisors 1,038,600$1,350,0000.01%
Alyeska Investment Group, L.P. 444,738$578,0000.01%
MILLENNIUM MANAGEMENT LLC 600,000$780,0000.00%
Airain ltd 14,674$19,0000.00%
View complete list of BIOLINERX LTD shareholders